CDKN2A and glioblastoma: They suggested that CDKN2A deletion could remodel the distribution of polyunsaturated fatty acids into different lipid compartments, sensitizing glioblastomas with CDKN2A loss to lipid peroxidation and ferroptosis both in vitro and in vivo [47].